We are live on ! Find out more
NDRA icon

ENDRA Life Sciences

11 hedge funds and large institutions have $1.97M invested in ENDRA Life Sciences in 2020 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

187% more capital invested

Capital invested by funds: $686K → $1.97M (+$1.29M)

100% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 3

22% more funds holding

Funds holding: 911 (+2)

0% more ownership

Funds ownership: 0%0% (+0%)

Holders
11
Holders Change
+2
Holders Change %
+22.22%
% of All Funds
0.19%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
1
Reduced
Closed
3
Calls
Puts
Net Calls
Net Calls Change

NDRA Hedge Fund Activity: Q4 2020 in Review

11 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in ENDRA Life Sciences (NDRA) for Q4 2020, worth a combined $1.97M — up 187% from $686K a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new NDRA positions and 3 closed out — a net gain of 3 holders — while 1 added to existing stakes and 0 trimmed.

The largest buyer was Worth Venture Partners, opening a new position worth an estimated $240K. The largest seller was Citadel Advisors, exiting entirely with an estimated $33K sold.

  • 11 institutional investors held ENDRA Life Sciences (NDRA) as of Q4 2020, up from 9 in Q3 2020.
  • Funds reported $1.97M of ENDRA Life Sciences stock for Q4 2020, up 187% quarter-over-quarter.
  • 6 funds opened new ENDRA Life Sciences positions in Q4 2020 and 3 closed out, a net change of +3 holders.
  • The largest ENDRA Life Sciences buyer in Q4 2020 was Worth Venture Partners, an estimated $240K added.
  • The largest ENDRA Life Sciences seller in Q4 2020 was Citadel Advisors, an estimated $33K sold.

Based on aggregated 13F filings for Q4 2020.